<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Takeda’s Dengue Vaccine Candidate Associated with Reduced Incidence of Dengue in Children and Adolescents; New 18-Month Interim Phase 2 Data Published in The Lancet Infectious Diseases	</title>
	<atom:link href="https://www.novumpr.nl/2017/11/07/takedas-dengue-vaccine-candidate-associated-with-reduced-incidence-of-dengue-in-children-and-adolescents-new-18-month-interim-phase-2-data-published-in-the-lancet-infectious-diseases/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2017/11/07/takedas-dengue-vaccine-candidate-associated-with-reduced-incidence-of-dengue-in-children-and-adolescents-new-18-month-interim-phase-2-data-published-in-the-lancet-infectious-diseases/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=takedas-dengue-vaccine-candidate-associated-with-reduced-incidence-of-dengue-in-children-and-adolescents-new-18-month-interim-phase-2-data-published-in-the-lancet-infectious-diseases</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Tue, 07 Nov 2017 08:35:29 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
</channel>
</rss>
